Orthopedic implant infection: Prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999;Infección de implantes osteoarticulares: Factores pronósticos e influencia del tratamiento antibiótico prolongado en su evolución. Estudio prospectivo, 1992-1999

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 5, 2003, Pages 232-236

  Gómez, Joaquín ^a   Rodríguez, María ^a   Baños, Víctor ^a   Martínez, Lorenzo ^a   Claver, Ma Antonia ^a   Ruiz, Joaquín ^a   Simarro, Encarna ^a   Cánovas, José Antonio ^a   Medina, Manuel ^a   Clavel, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Antibiotic treatment; Orthopedic implants; Prognosis factors

Indexed keywords

CEFUROXIME; CEFUROXIME AXETIL; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ADULT; AGED; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CELL LABELING; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG TOLERANCE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HIP PROSTHESIS; HUMAN; IMPLANT; INFECTION COMPLICATION; JOINT PROSTHESIS; JOINT SURGERY; KNEE PROSTHESIS; LENGTH OF STAY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; PRESCRIPTION; PROGNOSIS; RELAPSE; SCINTISCANNING; SHOULDER; STAPHYLOCOCCUS; SURGICAL INFECTION; TREATMENT FAILURE;

EID: 0037531215     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13046541     Document Type: Article

References (22)

1. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg (Am) 1998;80:910-22.
2. Fitzgerald RH, Nolan DR, Ilstrup DN, Van Scoy RE, Washington JA, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg (Am) 1977;59:847-55.
3. Gómez J, Rodríguez M, Baños V, Martínez L, Claver MA, Ruiz J, et al. Infección de prótesis articulares: epidemiología y clínica. Estudio prospectivo 1992-99. Enf Infecc Microbiol Clin 2002;20:74-7.
4. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. J Bone Joint Surg (Am) 1996;78:512-23.
5. Karchmer AW. Editorial response: Salvage of infected orthopedic devices. Clin Infect Dis 1998;27:714-6.
6. Mader JT, Shirtliff M, Calhoum JH. Staging and staging application osteomyelitis. Clin Infect Dis 1997;25:1303-9.
7. Coventry MB. Treatment in infections occurring in total hip surgery. Orthop Clin North Am 1975;6:991-1003.
8. Sanchez B, Gomis M. Tratamiento antibiótico de la osteomielitis bacteriana. En: García Sánchez JE, López R, Prieto J, editores. Antimicrobianos en Medicina. Barcelona: Prous Science, 1999; p. 525-30.
9. Gillespie WJ. Prevention and management of infection after total joint replacement. Clin Infect Dis 1997;25:1310-7.
10. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of staphylococcal-infected orthopedic implants. Antimicrob Agents Chemother 1993;37:1214-8.
11. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE, for the Foreign-Body Infection (FBI) Study Group. Role of rifampin for the treatment of orthopedic implant-related staphylococcal infections. A randomized controlled trial. JAMA 1998;279:1537-41.
12. Wilmer AF, Gächter A, Aschner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992;14:1251-3.
13. Lew DP, Waldvogel FA. Use of quinolones in osteomyelitis and infected orthopaedic prosthesis. Drugs 1999;58(Suppl 2):85-91.
14. Materson EL, Masri BA, Duncan CP. Treatment of infection at the site of total hip replacement. J Bone Joint Surg (Am) 1997;79:1740-9.
15. Segawa H, Tsukuyama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. J Bone Joint Surg (Am) 1999;81:1434-45.
16. Tattevin P, Cremieux AC, Pottier P, Huten D, Carbon C. Prosthetic joint infection: When can prosthesis salvage be considered? Clin Infect Dis 1999;29:292-5.
17. Brause BD. Infections with prostheses in bones and joins. En: Mandell GL, Bennett JE, Dolling R, editors. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000; p. 1196-200.
18. Barberán J, Carroquino G, Gomis M. Preguntas y respuestas sobre infecciones de prótesis articulares. Enf Infecc Microbiol Clin 2000;18:370-5.
19. o VI. Madrid, 2001; p. 9-15.
20. Norden CW. Antibiotic prophylactic in orthopedic surgery. Rev Infect Dis 1991;13(Suppl 10):842-6.
21. Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother 1996;40:2675-9.
22. Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections. Clin Pharmacokinet 1995;29:36-45.